A World Health Organization (WHO) panel on Friday recommended the synthetic antibody treatment Regeneron for COVID-19, but only in patients with specific health profiles.  

Persons with non-severe COVID-19 who are nonetheless at high risk of hospitalization can take the antibody combo, as should critically ill patients unable to mount an adequate immune response, according to a WHO finding published in the British Medical Journal.